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ABSTRACT
Objectives: The airway instrumentation of direct laryngoscopy and tracheal intubation is powerful noxious stimuli that should be attenuated by 
appropriate premedication, smooth induction, and rapid intubation. This study compared the efficacy intravenous dexmedetomidine and oral 
pregabalin premedication for attenuation of hemodynamic pressor response to laryngoscopy and intubation.
Methods: A total of 60 patients of age group 20-50 years scheduled for elective surgeries under general anesthesia with American Society of 
Anesthesiologists physical Status I and II were divided into two groups each of 30. Group D received intravenous dexmedetomidine 1 mcg/kg over 
10 minutes before induction, and Group P received oral pregabalin 150 mg 1 hr before intubation. Parameters observed were heart rate (HR) and 
mean arterial pressure (MAP) at baseline, after induction, immediately after intubation and then 5, 10, 15, and 30 minutes thereafter.
Results: Attenuation of HR in group dexmedetomidine (78.12±10.0/minutes) immediately after intubation was statistically significant than group 
pregabalin (89.76±10.45/minutes). MAP significantly (p<0.05) decreased after intubation with dexmedetomidine. As compared to oral pregabalin, 
attenuation of HR and MAP was statistically significant till 30 minutes after intubation with intravenous dexmedetomidine.
Conclusion: Intravenous dexmedetomidine 1 µg/kg is more effective than oral pregabalin 150 mg in attenuating hemodynamic response to 
laryngoscopy and orotracheal intubation.
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INTRODUCTION
Hemodynamic pressor response to laryngoscopy and endotracheal 
intubation provokes tachycardia and hypertension that can lead to 
many adverse events in patients with cardiovascular disease [1].
Dexmedetomidine, an imidazole derivative and highly selective 
α2 adrenergic receptor agonist, is being used widely to attenuate 
hemodynamic responses [2-4]. Pregabalin has analgesic, 
anticonvulsant, and anxiolytic effects [5,6]. Several studies have 
demonstrated the efficacy of oral pregabalin on post-operative 
analgesia and reduction of parenteral analgesics [7-9]. Oral pregabalin 
attenuates pressor response to laryngoscopy and endotracheal 
intubation [10,11].
The aim of this study was to compare the efficacy of intravenous 
dexmedetomidine and oral pregabalin in attenuating the hemodynamic 
response to laryngoscopy and endotracheal intubation.
METHODS
The study was conducted after obtaining approval from Institutional 
Ethical Committee and informed patients consent during the period of 
July 2014-October 2015. This prospective, randomized, double-blinded 
controlled study was conducted on 60 patients of age group 20-50 years 
scheduled for elective surgeries under general anesthesia with 
American Society of Anesthesiologists (ASA) physical Status I and 
II. Patients with a history of the cardiac, pulmonary or renal disease, 
obesity, anticipated difficult intubation, allergic to any anesthetic 
medication, pregnant and lactating patients and those taking sedatives, 
hypnotics or antihypertensives were excluded from the study. We also 
excluded cases where laryngoscopy exceeded 20 seconds or a second 
attempt was needed. Both patients and observer were totally blind 
about the groups and medications given.
In the pre-operative room, baseline heart rate (HR) along with 
systolic, diastolic, and mean arterial blood pressure was recorded. 
Patients were randomly divided into two groups each of 30 patients 
by computer-generated random table. Group D received intravenous 
dexmedetomidine 1 mcg/kg over 10 minutes before induction, and 
Group P received oral pregabalin 150 mg 1 hr before intubation. 
A crystalloid intravenous fluid was started, and all the patients were 
premedicated with intravenous ranitidine (50 mg), ondansetron 
(8 mg), midazolam (1 mg), and glycopyrrolate (0.2 mg). After pre-
oxygenation for 3 minutes with 100% oxygen, anesthesia was 
induced with propofol (2 mg/kg) or in a dose sufficient for loss of 
verbal commands. The direct laryngoscopy and intubation were 
facilitated with vecuronium 0.1 mg/kg. Intravenous fentanyl 2 µg/kg 
was administered 15 minutes after intubation to avoid its effect on 
hemodynamic response. Anesthesia was maintained with isoflurane 
and nitrous oxide 60% in oxygen. Patients were mechanically ventilated 
to maintain the normocapnia. After completion of surgery, residual 
neuromuscular block was antagonized with appropriate intravenous 
doses of neostigmine (0.05 mg/kg) with glycopyrrolate (0.01 mg/kg), 
and extubation was performed when respiration was spontaneous and 
adequate.
Parameters observed were HR and mean arterial pressure (MAP) at 
baseline, after induction, immediately after intubation and then 5, 10, 
15, and 30 minutes thereafter. Decrease in MAP by more than 20% 
from baseline or systolic arterial pressure <90 mm Hg was treated by 
increasing the intravenous fluid infusion rate or incremental doses of 
ephedrine 5 mg IV bolus. Decrease in HR (<50 beats/minutes) was 
treated with atropine 0.5 mg IV.
Statistical analysis
The sample size was calculated by power analysis (power 80% and 
α error 0.05) from initial pilot studies. The calculated sample size for 
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each group was 23 patients. Presuming the dropout rate to be 5%, it 
was decided to include 30 patients each group. Data were expressed 
as mean±standard deviation and analyzed by Student’s t-test and 
Chi-square test. Probability (p) was considered to be significant if <0.05.
RESULTS
Out of the 60 patients, 30 patients in each group were evaluated and 
compared (Table 1). Patients demographic profile were similar in both 
groups. The duration of laryngoscopy and intubation was similar in both 
groups. No significant difference was found among them with respect to 
age, sex, weight, ASA grading, duration of laryngoscopy and anesthesia.
Attenuation of HR in group dexmedetomidine (78.12±10.0/minutes) 
immediately after intubation was statistically significant than group 
pregabalin (89.76±10.45/minutes) (Table 2). MAP significantly 
(p<0.05) decreased after intubation with dexmedetomidine as shown in 
Table 3. As compared to oral pregabalin, attenuation of HR and MAP was 
statistically significant till 30 minutes after intubation with intravenous 
dexmedetomidine. No post-operative respiratory depression, nausea, 
and vomiting were found, and no other post-operative complication 
was recorded in any group during our study.
DISCUSSION
Attenuation of the sympathoadrenal stress response is important 
especially in high-risk patients [12]. Various methods such as α or β 
adrenergic blockers, opioids, topical or systemic lignocaine are being used 
to attenuate hemodynamic response [13-15]. Dexmedetomidine possess 
anxiolytic, sedative, analgesic, and sympatholytic properties. It may be used 
as premedicant, adjunct to balanced anesthesia as it remarkably reduces 
the doses of the anesthetic drugs [16]. Pregabalin, (S)-3-(aminomethyl)-
5-methylhexonic acid is a new structural, and non-functional analog 
of gamma-aminobutyric acid acts at pre synaptic calcium channels to 
modulate neurotransmitter release in the central nervous system (CNS) 
and used as an adjuvant in the treatment of partial seizures, general 
anxiety disorders, neuropathic pain (1-2). Pregabalin (pree-γ-lin) binds to 
the α2-δ site an auxiliary subunit of voltage-gated calcium channels in the 
CNS, inhibiting excitatory neurotransmitter release. [17].
In our study, intravenous dexmedetomidine was found to be more 
effective than oral pregabalin in attenuating hemodynamic response 
to laryngoscopy and endotracheal intubation. Dexmedetomidine 
produces hyperpolarization of noradrenergic neurons and suppression 
of neuronal firing in the locus cerelous that leads to decrease in systemic 
noradrenalin release and attenuation of sympathoadrenal response 
during laryngoscopy and intubation [4]. There was statistically 
significant difference (p<0.05) inchange of mean HR and MAP between 
the oral pregabalin and dexmedetomidine group immediately the 
following intubation. Attenuation of HR and MAP was significant up to 
30 minutes after intubation with intravenous dexmedetomidine.
The previous study has shown that oral pregabalin at dose 75 mg 
was not effective in attenuating pre-operative anxiety and at a dose of 
300 mg produced increased level of sedation after surgery [18]. Based 
on the result of the previous study, the dose of pregabalin was chosen 
as 150 mg [10].
Chaudhary et al. have shown that oral pregabalin and clonidine have 
both effectively blunt hemodynamic pressure response to laryngoscopy 
without prolongation of recovery time and side effects [19]. It is found 
that intravenous dexmedetomidine is more effective in attenuating the 
hemodynamic response to laryngoscopy and intubation than other 
agents [3,20-22].
When assessing techniques to lessen the hemodynamic pressor 
responses of airway instrumentation, the induction agents may 
influence the results. We have used propofol as an induction agent, 
which produces hypotension more than thiopental and bradycardia, 
which has helped to compensate in part the hemodynamic changes 
induced due to laryngoscopy and intubation in all patients [23]. 
The salivary and tracheobronchial mucus secretions necessitate 
prophylactic administration of intravenous glycopyrrolate.
The limitation of the study was that sedation score and recovery time 
was not compared.
CONCLUSION
Intravenous dexmedetomidine 1 µg/kg is more effective than 
oral pregabalin 150 mg in attenuating hemodynamic response to 
laryngoscopy and orotracheal intubation.
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